Key result
Type 2 diabetic db/db mice exhibited significantly attenuated cardiac inotropic and lusitropic responses during dobutamine stress testing, associated with metabolic but not structural remodelling.
Why the study?
Does type 2 diabetes in db/db mice impair cardiac functional reserve and is it associated with metabolic or structural remodelling?
Does type 2 diabetes in db/db mice impair cardiac functional reserve and is it associated with metabolic or structural remodelling?
In type 2 diabetic db/db mice, impaired cardiac functional reserve during beta-adrenergic stimulation is associated with early metabolic changes rather than structural remodelling.
Answers are grounded in this paper and cite their sources.
Metabolic remodelling may impair cardiac reserve before structural changes in T2D models; leaves open translation to human diabetic cardiomyopathy.
AIM: To identify the initial alterations in myocardial tissue associated with the early signs of diabetic cardiac haemodynamic dysfunction, we monitored changes in cardiac function, structural remodelling and gene expression in hearts of type 2 diabetic db/db mice. METHODS: Cardiac dimensions and function were determined echocardiographically at 8, 12, 16 and 18 weeks of age. Left ventricular pressure characteristics were measured at 18 weeks under baseline conditions and upon dobutamine infusion. RESULTS: The db/db mice were severely diabetic already at 8 weeks after birth, showing elevated fasting blood glucose levels and albuminuria. Nevertheless, echocardiography revealed no significant changes in cardiac function up to 18 weeks of age. At 18 weeks of age, left ventricular pressure characteristics were not significantly different at baseline between diabetic and control mice. However, dobutamine stress test revealed significantly attenuated cardiac inotropic and lusitropic responses in db/db mice. Post-mortem cardiac tissue analyses showed minor structural remodelling and no significant changes in gene expression levels of the sarcoplasmic reticulum calcium ATPase (SERCA2a) or beta1-adrenoceptor (beta1-AR). Moreover, the phosphorylation state of known contractile protein targets of protein kinase A (PKA) was not altered, indicating unaffected cardiac beta-adrenergic signalling activity in diabetic animals. By contrast, the substantially increased expression of uncoupling protein-3 (UCP3) and angiopoietin-like-4 (Angptl4), along with decreased phosphorylation of AMP-activated protein kinase (AMPK) in the diabetic heart, is indicative of marked changes in cardiac metabolism. CONCLUSION: db/db mice show impaired cardiac functional reserve capacity during maximal beta-adrenergic stimulation which is associated with unfavourable changes in cardiac energy metabolism.
No takes yet. Share an insight, caveat, or question.
Daniels et al. (2010) studied Type 2 diabetes. Type 2 diabetes (db/db genotype) vs. Control mice was evaluated on Cardiac inotropic and lusitropic responses upon dobutamine infusion at 18 weeks. Type 2 diabetic db/db mice exhibited significantly attenuated cardiac inotropic and lusitropic responses during dobutamine stress testing, associated with metabolic but not structural remodelling.
Synapse has enriched 10 related papers. Consider them for comparative context: